Interview with Nihal Aygun, CEO, Corena Turkey
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a professional experience in several…
Address: 2545. Sokak Toyko Villalari No:14 Umitkoy / Yenimahalle / Ankara / TURKEY
2545. Sokak Toyko Villalari No:14 Umitkoy / Yenimahalle / Ankara / Turkey
Tel: +90 312 236 43 34
Web: http://www.corena.com.tr/
CORENA has been successfully serving to its clients worldwide since 1998 with an overall focus to help clients locate new areas of expansion within the marketplace, to implement best practices for achieving success and to achieve high growth levels in these areas of opportunity. With our extensive geographic coverage we are committed to consistently striving to deliver relevant tailored solutions,
Authenticity, happiness, passion, commitment and responsibility are the key words in the daily life of our company…
FIELD OF ACTIVITIES
INTERNATIONAL SALES
CLINICAL TRIALS
Weprovide governments, multilateral and procurement agencies, non-governmental organisations, charities, missionary groups, pharmaceutical wholesalers, hospitals and retail chemistsin 53 differentcountrieswithwiderangeof productssuch as:
PHARMACEUTICALS
OTC PRODUCTS
VACCINES
MEDICAL DEVICES
COSMETICS
DIET PRODUCTS
VETERINARIAN PRODUCTS
DIAGNOSTICS
CLINICAL TRIALS
CORENA dispatchesproductstoclinicaltrial centres across the worldwiththebestdeliveryconditonssuch as:
Cold chain and ambient supply chain
Fully tracked deliveries including temperature control
Specialized andExperienced Team
CORENA’S DIFFERENCE
With 15 yearsexperiece of sourcingquality- assuredandreliableproducts, wehavebeenabletobuildupstrong global supplierrelationship,andyou can alwaysdepend on thequality of CORENA’sproducts, BECAUSE WE DIFFER FROM THE OTHERS IN MANY ASPECTS SUCH AS:
OFFERINGS
LOGISTICS
SECURITY
LICENCES
CONFIDENTIALTY
EXPERIENCED AND SPECIALIZED TEAM
OUR OFFERINGS
Whereveryouare,operateorwork, our experienced multi-lingual team are able to source pharmaceuticals and other medical products for you in any quantity at any time and at any competitive price.
Weoffer awiderange of packagingoptionsincludingvalidatedboxesandmaterialsforcoldchainandhazardousitems.
Wearealsoquiteeffectivewiththeshipment of theorders. 90 % of yourproductsaredispatchedwithin 3-4 daysdays. As forthe life-savingmedicineswe do ourbesttosendthem on thesameday.
STORAGE
Temperature of theproducts is monitored and recorded periodically. The records of temperature are reviewed regularly.
Storage facilities arealwaysclean and free from litter, dust and pests.
Adequate precautions aretaken against spillage or breakage, attack by micro-organisms and cross contamination.
There is a system to ensure stock rotation (‘first in first out’) with regular and frequent checks that the system is operating correctly.
Products beyond their expiry date or shelf life are separated from usable stock and neither sold nor supplied.
Medicinal products with broken seals, damaged packaging, or suspected of possible contamination arewithdrawn from saleable stock, and if not immediately destroyed, they arekept in a clearly separated area in order not to be soldbe sold mistakenly, ortoavoidthecontamination o otherproducts.
LOGISTICS
CORENA will manage your shipment and ensure that your goods arrive in the best conditions at the right time and place, and with all correct documentation.
We offer:
• Delivery within 3-4 daysfor most products depending on destination
• Specialist packaging to ensure perfect condition on arrival including temperature sensitive, dangerous/hazardous and fragile
• Competitive freight alternatives around the world
COLD CHAIN
We frequently ship to over 53 countries and our specialist logistics team ensures deliveries go out on time from our fully licensed warehouse.
Cold chain deliveries:
CORENA has extensive experience in shipping temperature-sensitive goods across the globe using either refrigerated transport or insulated packaging.
We have full SOPs to cover all elements of temperature-sensitive transport and these are available for inspection by our clients. CORENA uses temperature boxes and tracks all shipments using temperature loggers. We are, of course, willing to abide by any trial protocols and use differing technologies if necessary.
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a professional experience in several…
Keyman’s general manager discusses his firm’s development efforts towards vaccine production, in conjunction with TUBITAK and Hacettepe University, and their geographic expansion into Africa, Latin America, and Southeast Asia. Please…
A recent arrival from China, Lilly’s Turkey MD Daniel Lucas assesses the country’s healthcare system and raises key questions about the sustainability of the system at large going forward, and…
MSD Turkey has benefited in recent years from the ability to engage in local business development initiatives, and managing director Hatice Demiray has prioritized initiatives such as reducing internal bureaucracy…
GSK’s VP and Area GM Pharmaceuticals, Turkey and Caucasus, and chairman of Turkey’s innovative pharmaceutical association, discusses the effectiveness of the government’s current strategy for reducing the trade deficit in…
Imuneks is currently operating in the OTC market, but with three supergeneric products ready to market on the RX side, the firm has the potential to soon become one of…
Recordati’s South East regional VP, based in Istanbul, discusses Recordati Turkey’s key role as a manufacturing hub for Recordati, the importance of the Turkish market (fourth largest globally for the…
Turkey is quickly becoming a regional hub for pharmaceutical industry for management, clinical trials and manufacturing, explains the general manager of Chiesi Turkey. How important is it for the government…
Biocodex’s new general manager gives an overview of the affiliates ‘new deal’ program, and how the company has adjusted its approach to better fit the contemporary Turkish environment. What attracted…
The general manager of Daiichi Sankyo Turkey discusses his affiliate’s expansion into a regional hub, current strategies for growth in the Turkish market, and the keys behind his affiliates multiple ‘great…
Turkey’s leading pharmaceutical company is in the process of developing production facilities abroad, and it has just begun construction of a USD 100 million biotech facility; CEO Süha Taşpolatoğlu believes…
The leadership of Turkey’s newest major pharmaceutical player, Pharmactive, discuss the firm’s two pronged growth strategy, detailing their own sales objectives and prospects, as well as the opportunities that they…
Polifarma is Turkey’s largest producer of basic parenteral IV solutions with a 41 percent market share the country and growing exports across the region. According to the Chairman and CEO…
See our Cookie Privacy Policy Here